持续按需膈肌神经刺激预防机械通气期间膈肌失活:一项1期临床试验(STIMULUS)
本研究为单中心1期临床试验,纳入因急性低氧性呼吸衰竭或胸外科术后接受有创机械通气的患者,经静脉膈肌神经刺激与机械通气同步,在呼吸机触发而患者未触发呼吸时给予刺激,直至成功完成自主呼吸试验或最长7天。共入组20例,19例接受研究操作,19例(100%)成功启动膈肌神经刺激;初始24小时内18/19(95%)在≥50%的被动机械通气小时数维持目标膈肌活动。7天研究期内,无呼吸驱动时维持膈肌活动的时数中位数为100%(四分位距95-100%)。作者认为持续按需膈肌神经刺激辅助机械通气可行,可预防机械通气期间膈肌失活。
要点
- 单中心1期试验中,20例入组、19例接受操作,19例(100%)成功启动经静脉膈肌神经刺激,刺激与机械通气同步。
- 初始24小时内,18/19(95%)患者在≥50%的被动机械通气小时数维持目标膈肌活动。
- 7天研究期内,无呼吸驱动时维持膈肌活动的时数中位数为100%(四分位距95-100%)。
- 膈肌神经刺激耐受良好;1例气胸与装置无关,发生于术前锁骨下静脉置管后。
- 作者结论:持续按需膈肌神经刺激辅助机械通气可行,可预防机械通气期间膈肌失活。
适用人群与场景
- 因急性低氧性呼吸衰竭或胸外科术后接受有创机械通气的患者;单中心1期临床试验人群。
处置流程与药物剂量
- 经静脉膈肌神经刺激与机械通气同步,在呼吸机触发而患者未触发呼吸时给予刺激,直至成功完成自主呼吸试验或最长7天。
红旗征与不能漏的情况
- 1例气胸与装置无关,发生于术前锁骨下静脉置管后。
研究设计与关键结果
- 单中心1期临床试验:入组20例,19例接受研究操作;19例(100%)成功启动膈肌神经刺激。
- 初始24小时内,18/19(95%)患者在≥50%的被动机械通气小时数维持目标膈肌活动。
- 7天研究期内,无呼吸驱动时维持膈肌活动的时数中位数为100%(四分位距95-100%)。
- 膈肌神经刺激耐受良好;1例气胸与装置无关,发生于术前锁骨下静脉置管后。
证据类型、等级与局限
- 证据类型:单中心1期临床试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为持续按需膈肌神经刺激辅助机械通气可行,可预防机械通气期间膈肌失活。
指南或共识出处
- 临床试验注册号:NCT05465083(www.clinicaltrials.gov)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Diaphragm inactivity during invasive mechanical ventilation may predispose the lung and diaphragm to injury and is associated with adverse clinical outcomes. Objectives: Assess the feasibility of continuous on-demand diaphragm neurostimulation-assisted mechanical ventilation to maintain diaphragm activity in the absence of respiratory drive for at least 24 hours of mechanical ventilation. Methods: In a single-center phase 1 clinical trial, patients receiving invasive mechanical ventilation for acute hypoxemic respiratory failure or after thoracic surgery underwent transvenous diaphragm neurostimulation delivered in synchrony with mechanical ventilation. Diaphragm neurostimulation was delivered when breaths were initiated by the ventilator and not by the patient until a successful spontaneous breathing trial was performed or for up to 7 days. The coprimary outcomes were safety and feasibility of maintaining diaphragm activity over the first 24 hours of intervention. Measurements and Main Results: Twenty participants were enrolled and 19 underwent study procedures. Diaphragm neurostimulation was successfully initiated in all 19 patients (100%), and on-target diaphragm activity was maintained for ⩾50% of hours of passive mechanical ventilation over the initial 24-hour period in 18/19 (95%) patients. Diaphragm neurostimulation was well tolerated; one pneumothorax unrelated to the device occurred after subclavian catheter placement before surgery. Over the 7-day study period, diaphragm activity was maintained during a median of 100% (interquartile range, 95-100%) hours with absent respiratory drive. Conclusions: Continuous on-demand diaphragm neurostimulation-assisted mechanical ventilation is feasible and can prevent diaphragm inactivity during mechanical ventilation. Clinical Trial registered with www.clinicaltrials.gov (NCT05465083).
参考来源
- Morris IS, Bassi T, Bellissimo CA, et al. Continuous On-Demand Diaphragm Neurostimulation to Prevent Diaphragm Inactivity During Mechanical Ventilation: A Phase 1 Clinical Trial (STIMULUS). Am J Respir Crit Care Med. 2025. PMID: 40043207. doi:10.1164/rccm.202407-1483OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。